85966-018 Vrenmol Extra Strength Nail Renewal Patches

Manufacturer
GUANGZHOU SAWEILAN IMPORT & EXPORT TRADING CO., LTD | Guangzhou Meixi Biotechnology Co., Ltd.
Effective date
2026-05-21
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:58:27

Label at a glance#

ProductVrenmol Extra Strength Nail Renewal Patches
Active ingredientTOLNAFTATE
Label structure11 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

TOLNAFTATE(1%)

OTC - PURPOSE SECTION

Antifungal

INDICATIONS & USAGE SECTION

For effective treatment of most athlete's foot (tinea pedis), jock itch (tinea cruris), and ringworm(tinea corporis).
For effective relief of itching, scaling, cracking, burning, redness, soreness, irritation, discomfort and chafing associated with jock itch.
Proven effective in the prevention of most athlete's foot (tinea pedis) with daily use.

WARNINGS SECTION

For external use only Store in a cool place and avoid sunshine and heat.

OTC - DO NOT USE SECTION

Do not use · on children under 2 years of age unless directed by a doctor.

OTC - WHEN USING SECTION

When using this product · avoid contact with the eyes or damaged skin. It's normal to feel a slight, temporary sensation ofirritation, tingling, or burning. If symptoms persist or worsen,discontinue use.

OTC - STOP USE SECTION

Stop use and ask a doctor if · irritation occurs or if there is no improvement within 4 weeks

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children· If swallowed, get medical help or contact a Poison Control Center right away

DOSAGE & ADMINISTRATION SECTION

Clean and dry the affected nail and surrounding area

Remove the patch from its protective film.

Place it directly onto the infected nail, ensuring full coverage.
Gently press down on the edges of the patch to make sure it is firmly adhered to the nail and skin, with no air bubbles.
Keep the patch on for 24 hours. Replace it once a day, preferably after showering.
This product is not effective on the scalp or nails.

INACTIVE INGREDIENT SECTION

UREA
MELALEUCA
TEA TREE OIL
ALTERNIFOLIA (TEATREE) LEAF OIL
ORIGANUM VULGARE LEAF OIL
LAVANDULA
ANGUSTIFOLIA(LAVENDER) OIL
PROPYLENE
GLYCOL
POLYURETHANE
ACRYLATES
COPOLYMER

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

label5label5

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2677690tolnaftate 1 % Medicated PatchPSN1
2677690tolnaftate 0.01 MG/MG Medicated PatchSCD1
2677690tolnaftate 1 % Medicated PatchSY1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
85966-018-01Vrenmol Extra Strength Nail Renewal Patches34 in 1 BOXPATCH341
85966-018-01Vrenmol Extra Strength Nail Renewal Patches1 in 1 PATCHPATCH11

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85966-01885966-018-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Vrenmol Extra Strength Nail Renewal PatchesTOLNAFTATEGUANGZHOU SAWEILAN IMPORT & EXPORT TRADING CO., LTD52516861-e386-d0cb-e063-6394a90a17d02026-05-21WarningsExact identifier
ndc (package): 85966-018-01
ndc (product): 85966-018
ndc11 (package): 85966001801
spl id: 52516861-e387-d0cb-e063-6394a90a17d0
spl set id: 52516861-e386-d0cb-e063-6394a90a17d0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.